|
1
|
Oliva MS, Schottman T and Gulati M:
Turning the tide of corneal blindness. Indian J Ophthalmol.
60:423–427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan DT, Dart JK, Holland EJ and Kinoshita
S: Corneal transplantation. Lancet. 379:1749–1761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perera C, Jhanji V, Lamoureux E, Pollock
G, Favilla I and Vajpayee RB: Clinical presentation, risk factors
and treatment outcomes of first allograft rejection after
penetrating keratoplasty in early and late postoperative period.
Eye (Lond). 26:711–717. 2012. View Article : Google Scholar
|
|
4
|
Song J and Huang YF: Characteristics of
corneal endothelium during allograft rejection after corneal
transplantation. Zhonghua Yan Ke Za Zhi. 47:281–284. 2011.(In
Chinese).
|
|
5
|
Lowe MT, Keane MC, Coster DJ and Williams
KA: The outcome of corneal transplantation in infants, children,
and adolescents. Ophthalmology. 118:492–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Zhao S, Tang X, Ge H and Liu P:
Neutralization of mouse interleukin-17 bioactivity inhibits corneal
allograft rejection. Mol Vis. 17:2148–2156. 2011.PubMed/NCBI
|
|
7
|
Hegde S and Niederkorn JY: The role of
cytotoxic T lymphocytes in corneal allograft rejection. Invest
Ophthalmol Vis Sci. 41:3341–3347. 2000.PubMed/NCBI
|
|
8
|
Shi WY and Xie LX: The corneal allograft
rejection features in CD4 and CD8 knock-out mice. Zhonghua Yan Ke
Za Zhi. 41:350–354. 2005.(In Chinese).
|
|
9
|
Jessup CF, Brereton HM, Sykes PJ, Thiel
MA, Coster DJ and Williams KA: Local gene transfer to modulate rat
corneal allograft rejection. Invest Ophthalmol Vis Sci.
46:1675–1681. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang DJ, Guo HL, Huang YF, Chen GJ, Zhang
H and Li Y: Effects of a new immunodepressant J2 on lymphocytic
secretion of interleukin 10 and interferon gamma in mice after
corneal allograft. Journal of Clinical Rehabilitative Tissue
Engineering Research. 31:5797–5800. 2011.
|
|
11
|
Masli S, Turpie B, Hecker KH and Streilein
JW: Expression of thrombospondin in TGFβ-treated APCs and its
relevance to their immune deviation-promoting properties. J
Immunol. 168:2264–2273. 2002.
|
|
12
|
Okamoto S, Hara Y and Streilein JW:
Induction of anterior chamber-associated immune deviation with
lymphoreticular allogeneic cells. Transplantation. 59:377–381.
1995.PubMed/NCBI
|
|
13
|
Sano Y, Okamoto S and Streilein JW:
Induction of donor-specific ACAID can prolong orthotopic corneal
allograft survival in “high-risk” eyes. Curr Eye Res. 16:1171–1174.
1997.PubMed/NCBI
|
|
14
|
Tiao MM, Lu L, Huang LT, et al:
Cross-tolerance of recipient-derived transforming growth
factor-beta dendritic cells. Transplant Proc. 39:281–282. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan F, Cai L, Hui YN, Wang YS and Meng H:
Suppression effects of TGFβ2 -DC on corneal allograft rejection.
Guoji Yanke Zazhi. 2:346–349. 2007.(In Chinese).
|
|
16
|
Ezzelarab M and Thomson AW: Tolerogenic
dendritic cells and their role in transplantation. Semin Immunol.
23:252–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang T, Xu L, Li H, et al: Immature
CD4+ dendritic cells conditioned with donor kidney
antigen prolong renal allograft survival in rats. Chin Med J
(Engl). 125:2530–2537. 2012.
|
|
18
|
Liu WH, Liu JJ, Wu J, et al: Novel
mechanism of inhibition of dendritic cells maturation by
mesenchymal stem cells via interleukin-10 and the JAK1/STAT3
signaling pathway. PLoS One. 8:e554872013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li B and Hong J: Effects of topically
administered rapamycin on cytokine expression after penetrating
keratoplasty in rats. Chinese Ophthalmic Research. 25:850–853.
2007.
|
|
20
|
van Kooten C, Lombardi G, Gelderman KA, et
al: Dendritic cells as a tool to induce transplantation tolerance:
obstacles and opportunities. Transplantation. 91:2–7.
2011.PubMed/NCBI
|
|
21
|
Han B and Hu YH: Inhibitory mechanism of
CTLA4Ig-transfected DC in corneal transplantation. Chinese
Ophthalmic Research. 25:347–350. 2007.
|
|
22
|
Ouyang J, Fan C, Wen D, et al: Donor
antigen-loaded IKK2dn gene-modified dendritic cells prolong
allograft survival. Scand J Immunol. 71:336–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qu XY, Wang Y and Qin CH: Effects of U0126
on the process of immature dendritic cells inducing naive
CD4+ T cells to differentiate to Treg cells in vitro.
The Journal of Practical Medicine. 26:4476–4479. 2010.
|
|
24
|
Yang S, Li W, Liu W, et al: IL-10 gene
modified dendritic cells induced antigen-specific tolerance in
experimental autoimmune myocarditis. Clin Immunol. 121:63–73. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kushwah R, Oliver JR, Duan R, Zhang L,
Keshavjee S and Hu J: Induction of immunological tolerance to
adenoviral vectors by using a novel dendritic cell-based strategy.
J Virol. 86:3422–3435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Penna G and Adorini L: 1
Alpha,25-dihydroxyvitamin D3 inhibits differentiation,
maturation, activation, and survival of dendritic cells leading to
impaired alloreactive T cell activation. J Immunol. 164:2405–2411.
2000.PubMed/NCBI
|
